Pasquale Narciso

3.0k total citations
35 papers, 2.1k citations indexed

About

Pasquale Narciso is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Pasquale Narciso has authored 35 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Infectious Diseases, 27 papers in Virology and 9 papers in Emergency Medicine. Recurrent topics in Pasquale Narciso's work include HIV Research and Treatment (27 papers), HIV/AIDS drug development and treatment (26 papers) and HIV/AIDS Research and Interventions (19 papers). Pasquale Narciso is often cited by papers focused on HIV Research and Treatment (27 papers), HIV/AIDS drug development and treatment (26 papers) and HIV/AIDS Research and Interventions (19 papers). Pasquale Narciso collaborates with scholars based in Italy, United States and France. Pasquale Narciso's co-authors include Andrea Antinori, Valerio Tozzi, Giuseppe Ippolito, Pietro Balestra, Marinella Giulianelli, Rita Bellagamba, Patrizio Pezzotti, Maria Paola Trotta, Simonetta Galgani and Ubaldo Visco‐Comandini and has published in prestigious journals such as Clinical Infectious Diseases, The American Journal of Medicine and The Journal of Infectious Diseases.

In The Last Decade

Pasquale Narciso

35 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pasquale Narciso Italy 19 1.6k 1.4k 661 376 94 35 2.1k
Valerio Tozzi Italy 21 1.2k 0.7× 1.2k 0.9× 637 1.0× 281 0.7× 109 1.2× 40 1.7k
Simona Di Giambenedetto Italy 25 1.6k 1.0× 1.4k 1.0× 556 0.8× 323 0.9× 72 0.8× 121 2.1k
Stephen Taylor United Kingdom 29 1.5k 0.9× 1.1k 0.7× 289 0.4× 652 1.7× 124 1.3× 79 2.4k
Marlene Smurzynski United States 17 1.0k 0.6× 889 0.6× 755 1.1× 304 0.8× 53 0.6× 24 1.7k
Michael F. Para United States 21 1.3k 0.8× 1.0k 0.7× 411 0.6× 531 1.4× 128 1.4× 55 2.0k
Bernard Macatangay United States 21 856 0.5× 919 0.6× 548 0.8× 337 0.9× 140 1.5× 51 1.6k
Luuk Gras Netherlands 25 1.2k 0.7× 789 0.6× 346 0.5× 844 2.2× 266 2.8× 54 2.3k
Uriel Sandkovsky United States 17 897 0.5× 623 0.4× 206 0.3× 403 1.1× 149 1.6× 48 1.5k
Ireneus P.M. Keet Netherlands 24 898 0.5× 1.7k 1.2× 183 0.3× 568 1.5× 190 2.0× 33 3.2k
Aylin Yilmaz Sweden 24 1.1k 0.7× 876 0.6× 361 0.5× 256 0.7× 161 1.7× 68 1.8k

Countries citing papers authored by Pasquale Narciso

Since Specialization
Citations

This map shows the geographic impact of Pasquale Narciso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pasquale Narciso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pasquale Narciso more than expected).

Fields of papers citing papers by Pasquale Narciso

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pasquale Narciso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pasquale Narciso. The network helps show where Pasquale Narciso may publish in the future.

Co-authorship network of co-authors of Pasquale Narciso

This figure shows the co-authorship network connecting the top 25 collaborators of Pasquale Narciso. A scholar is included among the top collaborators of Pasquale Narciso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pasquale Narciso. Pasquale Narciso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Focà, Emanuele, Davide Motta, Marco Borderi, et al.. (2012). Prospective evaluation of bone markers, parathormone and 1,25-(OH)2 vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz. BMC Infectious Diseases. 12(1). 38–38. 35 indexed citations
2.
Narciso, Pasquale, Raffaella Bucciardini, Valerio Tozzi, et al.. (2009). Immediate versus Delayed Surgical Intervention for Reconstructive Therapy of HIV-Associated Facial Lipoatrophy: A Randomized Open-Label Study. AIDS Research and Human Retroviruses. 25(10). 979–987. 6 indexed citations
3.
Tozzi, Valerio, Pietro Balestra, Maria Flora Salvatori, et al.. (2009). Changes in Cognition During Antiretroviral Therapy: Comparison of 2 Different Ranking Systems to Measure Antiretroviral Drug Efficacy on HIV-Associated Neurocognitive Disorders. JAIDS Journal of Acquired Immune Deficiency Syndromes. 52(1). 56–63. 109 indexed citations
4.
Sarmati, Loredana, Emanuele Nicastri, Chiara Tommasi, et al.. (2009). Prognostic factors of long‐term CD4+count‐guided interruption of antiretroviral treatment. Journal of Medical Virology. 81(3). 481–487. 9 indexed citations
5.
Santoro, Maria Mercedes, Ada Bertoli, Patrizia Lorenzini, et al.. (2009). Two Different Patterns of Mutations are Involved in the Genotypic Resistance Score for Atazanavir Boosted Versus Unboosted by Ritonavir in Multiple Failing Patients. Infection. 37(3). 233–243. 7 indexed citations
6.
Tozzi, Valerio, Rita Bellagamba, Filippo Castiglione, et al.. (2008). Plasma HIV RNA Decline and Emergence of Drug Resistance Mutations among Patients with Multiple Virologic Failures Receiving Resistance Testing-Guided HAART. AIDS Research and Human Retroviruses. 24(6). 787–796. 4 indexed citations
7.
Dianzani, F., Gabriella Rozera, Isabella Abbate, et al.. (2008). Interferon May Prevent HIV Viral Rebound After HAART Interruption in HIV Patients. Journal of Interferon & Cytokine Research. 28(1). 1–3. 19 indexed citations
8.
Svicher, Valentina, Stefano Aquaro, Roberta D’Arrigo, et al.. (2008). Specific Enfuvirtide‐Associated Mutational Pathways in HIV‐1 Gp41 Are Significantly Correlated With an Increase in CD4+Cell Count, Despite Virological Failure. The Journal of Infectious Diseases. 197(10). 1408–1418. 35 indexed citations
9.
Ivanovic, Jelena, Emanuele Nicastri, Paolo Ascenzi, et al.. (2008). Therapeutic Drug Monitoring in the Management of HIV-Infected Patients. Current Medicinal Chemistry. 15(19). 1925–1939. 12 indexed citations
10.
Leone, Sebastiano, et al.. (2007). Eosinophilic Meningitis in a Returned Traveler From Santo Domingo: Case Report and Review. Journal of Travel Medicine. 14(6). 407–410. 38 indexed citations
11.
Tozzi, Valerio, Pietro Balestra, Rita Bellagamba, et al.. (2007). Persistence of Neuropsychologic Deficits Despite Long-Term Highly Active Antiretroviral Therapy in Patients With HIV-Related Neurocognitive Impairment. JAIDS Journal of Acquired Immune Deficiency Syndromes. 45(2). 174–182. 242 indexed citations
12.
Nicastri, Emanuele, Sara Leone, Claudio Angeletti, et al.. (2007). Sex issues in HIV-1-infected persons during highly active antiretroviral therapy: a systematic review. Journal of Antimicrobial Chemotherapy. 60(4). 724–732. 95 indexed citations
13.
Tozzi, Valerio, Pietro Balestra, Diego Serraino, et al.. (2005). Neurocognitive Impairment and Survival in a Cohort of HIV-Infected Patients Treated with HAART. AIDS Research and Human Retroviruses. 21(8). 706–713. 94 indexed citations
14.
Zaccarelli, Mauro, Valerio Tozzi, Patrizia Lorenzini, et al.. (2005). Multiple drug class-wide resistance associated with poorer survival after treatment failure in a cohort of HIV-infected patients. AIDS. 19(10). 1081–1089. 104 indexed citations
15.
Zaccarelli, Mauro, Carlo Federico Perno, Federica Forbici, et al.. (2004). Q151M‐Mediated Multinucleoside Resistance: Prevalence, Risk Factors, and Response to Salvage Therapy. Clinical Infectious Diseases. 38(3). 433–437. 23 indexed citations
16.
Tozzi, Valerio, Pietro Balestra, Simonetta Galgani, et al.. (2003). Neurocognitive Performance and Quality of Life in Patients with HIV Infection. AIDS Research and Human Retroviruses. 19(8). 643–652. 93 indexed citations
17.
Luca, Andrea De, Antonella Cingolani, Simona Di Giambenedetto, et al.. (2003). Variable Prediction of Antiretroviral Treatment Outcome by Different Systems for Interpreting Genotypic Human Immunodeficiency Virus Type 1 Drug Resistance. The Journal of Infectious Diseases. 187(12). 1934–1943. 83 indexed citations
18.
D’Offizi, Gianpiero, et al.. (2002). Primary toxoplasma gondii infection in a pregnant human immunodeficiency virus-infected woman. The Pediatric Infectious Disease Journal. 21(10). 981–982. 5 indexed citations
19.
Tozzi, Valerio, Pietro Balestra, Simonetta Galgani, et al.. (2001). Changes in Neurocognitive Performance in a Cohort of Patients Treated With HAART for 3 Years. JAIDS Journal of Acquired Immune Deficiency Syndromes. 28(1). 19–27. 66 indexed citations
20.
Tozzi, Valerio, et al.. (1989). Fluconazole treatment of cryptococcosis in patients with acquired immunodeficiency syndrome. The American Journal of Medicine. 87(3). 353–353. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Valerio Tozzi Breakdown of academic impact, for papers by Simona Di Giambenedetto Breakdown of academic impact, for papers by Stephen Taylor Breakdown of academic impact, for papers by Marlene Smurzynski Breakdown of academic impact, for papers by Michael F. Para Breakdown of academic impact, for papers by Bernard Macatangay Breakdown of academic impact, for papers by Luuk Gras Breakdown of academic impact, for papers by Uriel Sandkovsky Breakdown of academic impact, for papers by Ireneus P.M. Keet Breakdown of academic impact, for papers by Aylin Yilmaz
Rankless by CCL
2026